Pediatric Hematology and Oncology · 2001 · 10 citations · 6 references
MedicineHematologyOncologyChemotherapyNeoplasiaPediatric OncologyHematologic MalignanciesHematopoietic NeoplasmsPediatric LeukemiasPediatric TumorsClinical RemissionLeukemia ClassificationLeukemia PathologyMyeloid NeoplasmsNeuroblastoma BiologySecondary Malignancy Risk
The authors report the case of a 4-year-old boy with a diagnosis of stage IV neuroblastoma (NB), who had been treated with 6 cycles of cyclophosphamide, doxorubicin, cisplatin, and etoposide for 12 months. The patient reached partial remission and presented a diagnosis of acute myelomonocytic leukemia (M4 AML), confirmed by immunophenotyping. After 2 months of therapy for leukemia, the child died with both malignancies in activity. A necropsy histologically confirmed the simultaneity of the two diseases. The authors review the possibilities of this association. The review leads to the conclusion that AML can occur as a secondary malignancy after the onset of the neuroblastoma, or be suggested by a misdiagnosis. The simultaneous occurrence of both as described here is not, however, found in the literature, to the best of the authors' knowledge.
6
Cancer incidence, survival, and mortality for children younger than age 15 years
John L. Young, Lynn G. Ries, E. Silverberg et al. · Cancer · 1986 · 580 citations · Full text
Medicine, Oncology, Pediatrics +17
Epipodophyllotoxin-related acute myeloid leukemia: a study of 35 cases.
Ching‐Hon Pui, Mary V. Relling, G K Rivera et al. · PubMed · 1995 · 138 citations
Medicine, Oncology, Pharmacology +7